Stemtech (STEK) Change in Inventory (2021 - 2025)
Stemtech's (STEK) quarterly Change in Inventory came in at -$17276.0 in Q4 2025, down 112.34% year-on-year from $139984.0 in Q4 2024, and up 57.02% quarter-over-quarter from -$40193.0 in Q3 2025.
Stemtech (STEK) Change in Inventory (2021 - 2025) Analysis & Trends
Stemtech has disclosed Change in Inventory across 5 years of filings, most recently posting -$17276.0 for Q4 2025.
- Change in Inventory for Q4 2025 came in at -$17276.0, down 112.34% year-over-year; the trailing twelve-month figure through Dec 2025 was $19983.0 (down 86.59% YoY), and the FY2025 annual result was $19983.0, down 86.59% from the prior year.
- Change in Inventory came in at -$17276.0 for Q4 2025 at Stemtech, up from -$40193.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $277675.0 in Q4 2021 to a low of -$152590.0 in Q1 2022.
- The 5-year median for Change in Inventory is -$19330.0 (2022), against an average of $984.79.
- Across the five-year window, Change in Inventory sank 632.75% in 2023 and jumped 63170.8% in 2025, its largest moves.
- Stemtech's Change in Inventory stood at $277675.0 in 2021, then tumbled by 108.55% to -$23744.0 in 2022, then slumped by 50.58% to -$35754.0 in 2023, then surged by 491.52% to $139984.0 in 2024, then plunged by 112.34% to -$17276.0 in 2025.
- The last three Change in Inventory figures came in at -$17276.0 (Q4 2025), -$40193.0 (Q3 2025), and $86407.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 20.30 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -2.11 Mn |
| 10 | Stemtech | - | - | 354,677.00 | -17,276.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17,276.00 |
| Dec 31, 2025 | -17,276.00 |
| Sep 30, 2025 | -40,193.00 |
| Sep 30, 2025 | -40,193.00 |
| Jun 30, 2025 | 86,407.00 |
| Jun 30, 2025 | 86,407.00 |
| Mar 31, 2025 | -8,955.00 |
| Mar 31, 2025 | -8,955.00 |
| Dec 31, 2024 | 139,984.00 |
| Dec 31, 2024 | 139,984.00 |
| Jun 30, 2024 | -137.00 |
| Jun 30, 2024 | -137.00 |
| Mar 31, 2024 | 9,183.00 |
| Mar 31, 2024 | 9,183.00 |
| Dec 31, 2023 | -35,754.00 |
| Dec 31, 2023 | -35,754.00 |
| Sep 30, 2023 | -141,640.00 |
| Sep 30, 2023 | -141,640.00 |
| Jun 30, 2023 | 116,576.00 |
| Jun 30, 2023 | 116,576.00 |